Positive Outlook for Saudi Stock Market Next Week

A trader monitors the screen at the Saudi Exchange in Riyadh. (AFP)
A trader monitors the screen at the Saudi Exchange in Riyadh. (AFP)
TT
20

Positive Outlook for Saudi Stock Market Next Week

A trader monitors the screen at the Saudi Exchange in Riyadh. (AFP)
A trader monitors the screen at the Saudi Exchange in Riyadh. (AFP)

Saudi Arabia’s Tadawul All Share Index (TASI) ended the second week of March with a slight decline for the third consecutive week, closing down 0.73% at 11,725.88 points, compared to the previous week's close of 11,811.11 points.

In an analysis of the market performance during the week ending March 13, Dr. Suleiman Al-Humaid Al-Khalidi, a financial market analyst, told Asharq Al-Awsat that the market experienced a sharp decline not seen in years, coinciding with a drop in global markets, particularly in the US, where $2 trillion in value was wiped out in a single day.

This accounted for roughly 60% of the total market value of the Saudi stock market.

Al-Khalidi noted that the key player in the Saudi market is the banking sector, especially Al-Rajhi Bank's shares, which showed resilience and did not follow the downward trend. This was attributed to the strong profits reported by the banking sector in 2024.

The primary factors contributing to the market’s decline include global economic pressures, particularly US tariffs on most global economies, ongoing global uncertainty, and the Federal Reserve's tight monetary policies, he explained.

These factors have significantly impacted liquidity flows into financial markets. Additionally, fluctuations in global oil prices, despite recent stability, have also played a role.

This downturn has been accompanied by caution among sovereign wealth funds, investment institutions, and some portfolios in injecting new liquidity or altering their positions until there is more clarity in the financial markets, he went on to say.

Moreover, Al-Khalidi said that the Saudi stock market has not accurately reflected the true strength and size of the Saudi economy, which has grown to SAR 4 trillion, up from SAR 600 billion in 2016, before the launch of Vision 2030.

Additionally, the country’s GDP has reached approximately $1.1 trillion.

Looking ahead to the market's performance in the coming week, he noted that there are strong support levels at 11,550 points, followed by 11,450 points.

These levels could help shift the market toward an upward trajectory and better reflect the robust growth of the Saudi economy.

Al-Khalidi emphasized that the banking and energy sectors could play a leading role in driving the market higher, pushing the index beyond this week’s closing levels.

He also pointed out that some stocks are hitting new lows, presenting significant investment opportunities for those seeking safe havens with steady returns in the Saudi market.



Saudi Arabia Establishes Research Centers to Advance Biotech Strategy

A Saudi student is seen at the Analytical Chemistry Lab at King Abdullah University of Science and Technology. (KAUST)
A Saudi student is seen at the Analytical Chemistry Lab at King Abdullah University of Science and Technology. (KAUST)
TT
20

Saudi Arabia Establishes Research Centers to Advance Biotech Strategy

A Saudi student is seen at the Analytical Chemistry Lab at King Abdullah University of Science and Technology. (KAUST)
A Saudi student is seen at the Analytical Chemistry Lab at King Abdullah University of Science and Technology. (KAUST)

Saudi Arabia has made significant strides in the biotechnology sector following the launch of its national strategy in early 2024, aiming to position itself as a leading global hub in the field.

The Kingdom has witnessed rapid developments in regulatory frameworks and infrastructure, facilitating the establishment of research centers and specialized laboratories that drive progress toward the strategy’s goals.

Biotechnology is a broad scientific and technological discipline involving the use of microorganisms, cells, and biological systems to develop products and applications that benefit various industries. It is considered a key tool for fostering development and enhancing societal well-being.

Prince Mohammed bin Salman, Crown Prince and Prime Minister, launched the National Biotechnology Strategy in January last year, aiming to make the sector contribute 3% to the Kingdom’s non-oil GDP by 2040, with a total economic impact of 130 billion riyals ($35 billion).

The strategy is expected to drive the expansion of the biotechnology industry while creating high-quality jobs in the coming years, with more than 11,000 positions projected by 2030.

The global biotechnology market was valued at around $1.5 trillion in 2023 and is projected to reach $4 trillion by 2030, according to a report by consultancy firm Arthur D. Little last year.

The forecast underscores the sector’s rapid growth, positioning biotechnology not only as a driver of scientific advancement but also as a major economic opportunity.

Saudi Arabia has established specialized research centers and advanced laboratories while localizing key industries such as insulin and vaccine production. At the same time, the Kingdom has strengthened collaboration with global institutions, accelerating innovation and enhancing self-sufficiency.

Saudi Bio, the Kingdom’s first biotechnology firm focused on technology transfer and localizing biotech industries, has made significant strides in this effort.

Dr. Khaled Al-Mosa, the company’s founder and vice chairman, highlighted the Kingdom’s progress, emphasizing that Saudi Arabia’s transformation is not limited to infrastructure development but also includes building a supportive regulatory environment that has made it an attractive destination for biotech companies.

“Saudi Arabia has undergone a major shift since launching its biotechnology strategy,” Al-Mosa told Asharq Al-Awsat.

“The Kingdom has achieved several milestones, including establishing specialized research centers, advanced laboratories, and leading national companies in the biotech field,” he remarked.

Collaboration with leading global research and development institutions has been a key driver of Saudi Arabia’s progress in biotechnology, helping to develop new technologies and scientific breakthroughs, according to Al-Mosa.

He noted that the Kingdom has successfully localized several critical industries, including insulin and vaccine production, boosting self-sufficiency and reducing reliance on imports.

Saudi Arabia’s supportive regulatory framework has also facilitated the growth of biotech firms, Al-Mosa said. The national strategy has streamlined licensing procedures and introduced financial and customs incentives to attract local and foreign investment.

The Kingdom has further strengthened its research and training capabilities by establishing specialized training centers and offering research grants for scientists, accelerating innovation and production. These initiatives, he added, have positioned Saudi Arabia as a preferred destination for biotechnology companies.

Looking ahead, Al-Mosa expressed optimism about the sector’s growth, driven by continued investment in research, development, and training. He expects an increase in biotech startups and new projects, enhancing Saudi Arabia’s global competitiveness.